P0265 : IGF2 is an oncogenic driver in HCC and emerges as a potential target for therapies
Martínez-Quetglas, I., Pinyol, R., Dauch, D., Portela, A., Peix, J., Higuera, M., Zucman-Rossi, J., Esteller, M., Mazzaferro, V., Zender, L., Llovet, J.M.Volume:
62
Langue:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(15)30481-5
Date:
April, 2015
Fichier:
PDF, 57 KB
english, 2015